Uterine Fibroid Management

First-Line Medical Management

The American College of Radiology recommends NSAIDs and estrogen-progestin oral contraceptive pills as initial treatments to reduce fibroid-related bleeding symptoms 3, 1, 4
The American College of Obstetricians and Gynecologists suggests levonorgestrel-releasing intrauterine devices for effective long-term bleeding control 1, 2, 4
Tranexamic acid is a preferred nonhormonal alternative for patients who cannot or prefer not to use hormonal options, with significant reduction in menstrual blood loss 3, 1, 4

The American College of Obstetricians and Gynecologists recommends oral GnRH antagonists, such as elagolix, linzagolix, and relugolix, to reduce bleeding symptoms and fibroid volume by 18-30% 1, 2, 4
Combination hormone add-back therapy with low-dose estrogen and progestin is mandatory to mitigate hypoestrogenic side effects while maintaining efficacy 3, 1, 4

Hysteroscopic myomectomy is the procedure of choice for pedunculated submucosal fibroids <5 cm, offering shorter hospitalization and faster recovery 3, 5, 2
Laparoscopic myomectomy is preferred over open myomectomy for other fibroid locations, with shorter hospital stays and faster return to activities 2, 4
Hysterectomy provides definitive resolution of all fibroid-related symptoms, but should be avoided if less invasive procedures can provide adequate symptom relief 3, 5, 2

Uterine artery embolization (UAE) improves symptom scores and quality of life for up to 7 years, with 94% short-term and 85% long-term symptom improvement 3, 2, 4
UAE demonstrates superior fibroid diameter reduction (53%) compared to laparoscopic uterine artery occlusion (39%) 2, 4
MR-guided focused ultrasound (MRgFUS) can be considered, but has a higher reintervention rate (30%) compared to UAE (13%) 4

Postmenopausal patients should always undergo endometrial biopsy prior to intervention to rule out endometrial neoplasia and diagnose potential sarcoma 2
UAE demonstrates improvement in quality of life and symptom scores in patients with adenomyosis and fibroids, especially when fibroids predominate 3